Logo
x

Search

Subscribe Now

HLX02

Henlius Present P-III Data of HLX02 (biosimilar- trastuzumab) at ESMO

Henlius Present P-III Data of HLX02 (biosimilar- trastuzumab) at ESMO

  • September 17, 2020
Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China

Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China

  • August 17, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.